Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Alcon Research |
---|---|
Information provided by: | Alcon Research |
ClinicalTrials.gov Identifier: | NCT00761995 |
Safety and Efficacy of Brinzolamide Dosed TID With Dorzo;Amide Dosed TID in Reducing Intraocular Pressure in Patients With Open Angle Glaucoma or Ocular Hypertension
Condition | Intervention | Phase |
---|---|---|
Glaucoma Ocular Hypertension |
Drug: Azopt Drug: Cosopt |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Parallel Assignment, Safety/Efficacy Study |
Estimated Enrollment: | 120 |
Study Start Date: | August 2008 |
Estimated Primary Completion Date: | September 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Active Comparator
topical eye drop dosed 1 drop 3 times daily
|
Drug: Azopt
topical eye drop dosed 1 drop 3 times daily
|
2: Active Comparator
topical eye drop
|
Drug: Cosopt
topical eye drop dosed 1 drop 2 times daily
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
If of child bearing potential
* Must use a reliable means of contraception for the duration of the study or surgically sterilized.
Exclusion Criteria:
Responsible Party: | Alcon ( Sujatha Ayappan ) |
Study ID Numbers: | MA-CT-08-003 |
Study First Received: | September 26, 2008 |
Last Updated: | September 29, 2008 |
ClinicalTrials.gov Identifier: | NCT00761995 |
Health Authority: | India: Institutional Review Board |
Raised IOP |
Brinzolamide Glaucoma Eye Diseases Glaucoma, Open-Angle |
Vascular Diseases Tetrahydrozoline Hypertension Ocular Hypertension |
Cardiovascular Diseases |